J. Machiels Et Al. , "Phase 3 study of Pembrolizumab plus Chemoradiation (CRT) vs CRT alone for locally advanced head and neck squamous cell carcinoma (LA-HNSCC): KEYNOTE-412," JOURNAL FOR IMMUNOTHERAPY OF CANCER , vol.5, 2017
Machiels, J. Et Al. 2017. Phase 3 study of Pembrolizumab plus Chemoradiation (CRT) vs CRT alone for locally advanced head and neck squamous cell carcinoma (LA-HNSCC): KEYNOTE-412. JOURNAL FOR IMMUNOTHERAPY OF CANCER , vol.5 .
Machiels, J., Yen, C., Licitra, L., Rischin, D., Waldron, J., Burtness, B., ... Gregoire, V.(2017). Phase 3 study of Pembrolizumab plus Chemoradiation (CRT) vs CRT alone for locally advanced head and neck squamous cell carcinoma (LA-HNSCC): KEYNOTE-412. JOURNAL FOR IMMUNOTHERAPY OF CANCER , vol.5.
Machiels, Jean-Pascal Et Al. "Phase 3 study of Pembrolizumab plus Chemoradiation (CRT) vs CRT alone for locally advanced head and neck squamous cell carcinoma (LA-HNSCC): KEYNOTE-412," JOURNAL FOR IMMUNOTHERAPY OF CANCER , vol.5, 2017
Machiels, Jean-Pascal Et Al. "Phase 3 study of Pembrolizumab plus Chemoradiation (CRT) vs CRT alone for locally advanced head and neck squamous cell carcinoma (LA-HNSCC): KEYNOTE-412." JOURNAL FOR IMMUNOTHERAPY OF CANCER , vol.5, 2017
Machiels, J. Et Al. (2017) . "Phase 3 study of Pembrolizumab plus Chemoradiation (CRT) vs CRT alone for locally advanced head and neck squamous cell carcinoma (LA-HNSCC): KEYNOTE-412." JOURNAL FOR IMMUNOTHERAPY OF CANCER , vol.5.
@article{article, author={Jean-Pascal Machiels Et Al. }, title={Phase 3 study of Pembrolizumab plus Chemoradiation (CRT) vs CRT alone for locally advanced head and neck squamous cell carcinoma (LA-HNSCC): KEYNOTE-412}, journal={JOURNAL FOR IMMUNOTHERAPY OF CANCER}, year=2017}